Order Center
Product Name or No.
Keyword (Full Text)
MISSION shRNA-RNAi
MISSION siRNA
Molecular Formula
CAS No.
MDL No.
MSDS (Prod. No. Only)
Supplier X Reference
SubStructure
YFG Search
Product Catalog
→
Chemical Synthesis
→
Asymmetric Synthesis
→
Chiral Catalysts, Ligands, and Reagents
→ Other Organocatalysts
Print Preview
Other Organocatalysts
SD File Tutorial
SD File Viewers
Scroll Up
Scroll Down
Reset Table
Image
Description
Molecular Formula
Product #
(
R
)-(−)-
3,3′-Bis(3,5-dimethylphenyl)-
5,5′,6,6′,7,7′,8,8′-octahydro-
1,1′-bi-2-naphthol 97%
C
36
H
38
O
2
669180
(
S
)-(+)-3,3′-
Bis(3,5-dimethylphenyl)-
5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-
bi-2-naphthol 97%
C
36
H
38
O
2
669172
S
-
N
-(3,5-Di-
tert
-butylphenyl)-3-
methyl-2-(
N
-formyl-
N
-methylamino)butanamide 96%
C
21
H
34
N
2
O
2
693626
5a(
R
),10b(
S
)-
5a,10b-Dihydro-2-
(pentafluorophenyl)-4
H
,6
H
-
indeno[2,1-
b
][1,2,4]triazolo[4,3-
d
][1,4]oxazinium tetrafluoroborate 97%
C
18
H
11
BF
9
N
3
O
674788
5a(
S
),10b(
R
)-
5a,10b-Dihydro-2-
(pentafluorophenyl)-4
H
,6
H
-
indeno[2,1-
b
][1,2,4]triazolo[4,3-
d
][1,4]oxazinium tetrafluoroborate 97%
C
18
H
11
BF
9
N
3
O
667080
(5a
R
,10b
S
)-
5a,10b-Dihydro-2-(2,4,6-
trimethylphenyl)-4
H
,6
H
-
indeno[2,1-
b
]-1,2,4-
triazolo[4,3-
d
]-1,4-
oxazinium chloride monohydrate 97%
C
21
H
22
ClN
3
O · H
2
O
683973
(5a
S
,10b
R
)-
5a,10b-Dihydro-2-(2,4,6-
trimethylphenyl)-4
H
, 6
H
-indeno[2,1-
b
]-1,2,4-triazolo[4,3-
d
]-1,4-oxazinium chloride monohydrate 97%
C
21
H
22
ClN
3
O · H
2
O
683981
(–)-(
S
)-
N
-((
R
)-3,3-
Dimethylbutan-2-yl)-3,3-dimethyl-2-((1-
methyl-1
H
-imidazol-2-
yl)methylamino)butanamide 97%
C
17
H
32
N
4
O
680826
(
S
)-
N
-(3,5-
Dimethylphenyl)-3-methyl-2-
(
N
-formyl-
N
-
methylamino)butanamide 97%
C
15
H
22
N
2
O
2
693561
Site Use Terms
|
Terms and Conditions of Sale
|
Privacy
|
Copyrights © 2008 Sigma-Aldrich Co. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.
